Type 1 diabetes · San Antonio

Type 1 diabetes clinical trials in San Antonio

3 recruiting type 1 diabetes studies within range of San Antonio. Click any trial for full eligibility criteria and contact info.

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

NCT07076199 · Diabetes Mellitus, Type 1

Recruiting

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin glargine taken daily. The study will last for about 8.5 months.

PhasePhase 3

TypeInterventional

Age18 Years

WhereCullman, Alabama, United States + 192 more

SponsorNovo Nordisk A/S

▾Tap for detailsClick for full details — eligibility, all locations, contacts

193 sitesApply

Apply Open full pageClinicalTrials.gov ↗

ROME GS System Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the ROME GS System

NCT07518004 · Diabetes, Diabetes Melletus, Type 1, Diabetes Mellitus, Type 2

Recruiting

The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.

PhaseNA

TypeInterventional

Age18 Years

WhereEscondido, California, United States + 3 more

SponsorSenseonics, Inc.

▾Tap for detailsClick for full details — eligibility, all locations, contacts

4 sitesApply

Apply Open full pageClinicalTrials.gov ↗

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

NCT06706284 · Spinal Cord Injuries, Type 2 Diabetes

Recruiting

It is not known whether a new diabetes drug, semaglutide, is an effective treatment for type 2 diabetes for persons with spinal cord injury (SCI), a population at higher risk for this condition. Therefore, this study looks at the effect of semaglutide on glucose levels in the body and other information about type 2 diabetes and obesity.

PhasePhase 4

TypeInterventional

Age18 Years – 70 Years

WhereSan Antonio, Texas, United States + 1 more

SponsorMarzieh Salehi

▾Tap for detailsClick for full details — eligibility, all locations, contacts

2 sitesApply

Apply Open full pageClinicalTrials.gov ↗

← All type 1 diabetes trials (nationwide)